Miyuki Miki
- Oncology
- Rheumatology top 10%
- Hematology top 10%
- Surgery
- Epidemiology
- Co-authors
- Tomoyuki SakaiMasao TanakaYasufumi MasakiToshihiro FukushimaAkio NakajimaYoshimasa FujitaHisanori UmeharaHaruka Iwao
- Topics
- Multiple Myeloma Research and Treatments (4 papers)IgG4-Related and Inflammatory Diseases (3 papers)CNS Lymphoma Diagnosis and Treatment (3 papers)
- Cited by
- HematologyRheumatologyOncology
In The Last Decade
Miyuki Miki
20 papers receiving 355 citations
Peers
Comparison fields: 5 of 66
- Oncology 123
- Rheumatology 108
- Hematology 96
- Surgery 73
- Epidemiology 72
Countries citing papers authored by Miyuki Miki
This map shows the geographic impact of Miyuki Miki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miyuki Miki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miyuki Miki more than expected).
Fields of papers citing papers by Miyuki Miki
This network shows the impact of papers produced by Miyuki Miki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miyuki Miki. The network helps show where Miyuki Miki may publish in the future.
Co-authorship network of co-authors of Miyuki Miki
This figure shows the co-authorship network connecting the top 25 collaborators of Miyuki Miki. A scholar is included among the top collaborators of Miyuki Miki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miyuki Miki. Miyuki Miki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 11 | |
| 3 | 33 | |
| 4 | 43 | |
| 5 | 72 | |
| 6 | 23 | |
| 7 | Daily 500 mg valacyclovir is effective for prevention of Varicella zoster virus reactivation in patients with multiple myeloma treated with bortezomib. | 11 |
| 8 | [Once-weekly bortezomib plus dexamethasone therapy induced complete response, reducing severe gastrointestinal adverse events for a patient with relapsed multiple myeloma - a case report]. | 2 |
| 9 | Low-dose cytarabine plus aclarubicin for patients with previously untreated acute myeloid leukemia or high-risk myelodysplastic syndrome ineligible for standard-dose cytarabine plus anthracycline. | 9 |
| 10 | 13 | |
| 11 | 4 | |
| 12 | Iron chelation therapy with deferasirox induced complete remission in a patient with chemotherapy-resistant acute monocytic leukemia. | 54 |
| 13 | Efficacy and safety of bortezomib plus dexamethasone therapy for refractory or relapsed multiple myeloma: once-weekly administration of bortezomib may reduce the incidence of gastrointestinal adverse events. | 19 |
| 14 | [Intravascular large B-cell lymphoma: an important cause of fever of unknown origin]. | 3 |
| 15 | [Primary neurolymphomatosis of the cervical nerve root]. | 2 |
| 16 | Complete response obtained by bortezomib plus dexamethasone in a patient with relapsed multiple myeloma with multiple plasmacytomas. | 5 |
| 17 | Synergistic effects of topoisomerase I inhibitor, SN38, on Fas-mediated apoptosis. | 8 |
| 18 | Cisplatin augments FAS-mediated apoptosis through lipid rafts. | 23 |
| 19 | MRSA-pyomyositis in a patient with acute myelogenous leukemia after intensive chemotherapy. | 7 |
| 20 | 20 |
About Miyuki Miki
Miyuki Miki is a scholar working on Hematology, Genetics and Rheumatology, having authored 20 papers that have together received 363 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (4 papers), IgG4-Related and Inflammatory Diseases (3 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Hematology (96 citations), Rheumatology (108 citations) and Oncology (123 citations). Miyuki Miki has collaborated with scholars based in Japan and China. Frequent co-authors include Tomoyuki Sakai, Masao Tanaka, Yasufumi Masaki, Toshihiro Fukushima, Akio Nakajima, Yoshimasa Fujita, Hisanori Umehara, Haruka Iwao, Toshioki Sawaki and Takafumi Kawanami. Their work appears in journals such as The Journal of Immunology, PLoS ONE and Cellular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.